Synthesis and positive inotropic evaluation of 2-(4-(4-substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl[1,2,4]triazolo[4,3-a]quinolin-7-yl)-acetamides. 2008

Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
Key Laboratory of Natural Resources and Functional Molecules of Changbai Mountain, Affiliated Ministry of Education, Yanbian University College of Pharmacy, Yanji, Jilin, PR China.

In an attempt to search for more potent positive inotropic agents, a series of 2-(4-(4-substituted benzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamides was synthesized and their positive inotropic activities were evaluated by measuring left atrium stroke volume on isolated rabbit-heart preparations. Several compounds showed favorable activity compared with the standard drug Milrinone among which 2-(4-(4-(2-chlorobenzyloxy)-3-methoxybenzyl)-1,4-diazepan-1-yl)-N-(4,5-dihydro-1-methyl-[1,2,4]triazolo[4,3-a]quinolin-7-yl)acetamide 6e was found to have the most desirable potency with the 6.79 +/- 0.18% increased stroke volume (Milrinone: 1.67 +/- 0.64%) at a concentration of 1 x 10(-5) M in our in-vitro study. The chronotropic effects of those compounds having inotropic effects were also evaluated in this work.

UI MeSH Term Description Entries
D011804 Quinolines
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013318 Stroke Volume The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume. Ventricular Ejection Fraction,Ventricular End-Diastolic Volume,Ventricular End-Systolic Volume,Ejection Fraction, Ventricular,Ejection Fractions, Ventricular,End-Diastolic Volume, Ventricular,End-Diastolic Volumes, Ventricular,End-Systolic Volume, Ventricular,End-Systolic Volumes, Ventricular,Fraction, Ventricular Ejection,Fractions, Ventricular Ejection,Stroke Volumes,Ventricular Ejection Fractions,Ventricular End Diastolic Volume,Ventricular End Systolic Volume,Ventricular End-Diastolic Volumes,Ventricular End-Systolic Volumes,Volume, Stroke,Volume, Ventricular End-Diastolic,Volume, Ventricular End-Systolic,Volumes, Stroke,Volumes, Ventricular End-Diastolic,Volumes, Ventricular End-Systolic
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
January 2011, Chemical biology & drug design,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
November 2010, Archiv der Pharmazie,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
December 2012, Archiv der Pharmazie,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
May 2009, Bioorganic & medicinal chemistry letters,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
December 2009, Drug discoveries & therapeutics,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
August 2008, Bioorganic & medicinal chemistry letters,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
August 2010, Bioorganic & medicinal chemistry letters,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
July 2012, Bioorganic & medicinal chemistry letters,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
November 2013, Archives of pharmacal research,
Jing-Yuan Li, and Xun Cui, and Xue-Kun Liu, and Lan Hong, and Zhe-Shan Quan, and Hu-Ri Piao
September 2007, Archiv der Pharmazie,
Copied contents to your clipboard!